WHITEHAWK THERAPEUTICS, INC. (WHWK) Net income 2016–2025
WHITEHAWK THERAPEUTICS, INC. (WHWK) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$20.6MFY2025 · since FY2016: -$17.0M → -$20.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.6M | +67.7% |
| FY2024 | -$63.7M | +3.2% |
| FY2023 | -$65.8M | -8.7% |
| FY2022 | -$60.5M | +45.0% |
| FY2021 | -$110.1M | -3065.3% |
| FY2020 | -$3.5M | +85.1% |
| FY2019 | -$23.3M | -123.8% |
| FY2018 | -$10.4M | +51.4% |
| FY2017 | -$21.4M | -26.0% |
| FY2016 | -$17.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More WHWK financial trends
WHWK RevenueWHWK Net marginWHWK Gross profitWHWK Gross marginWHWK Operating incomeWHWK Operating marginWHWK Operating cash flowWHWK Free cash flowWHWK Capital expendituresWHWK Return on equityWHWK Stock buybacksWHWK Dividends paidWHWK Total assetsWHWK Total liabilitiesWHWK Shareholders’ equityWHWK overview →